Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-15

FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic ezetimibe and simvastatin combination product (EZETIMIBE AND SIMVASTATIN) from Ascend Laboratories, enabli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)